Cardiovascular Risk-Benefit Profile of Sibutramine

By Scheen A.J.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 5, 2010-10 ,pp. : 321-334

Adis International

Access to resources Recommend Favorite

RISK CHARACTERIZATION: PRINCIPLES AND PRACTICE

By Williams Pamela R. D.   Paustenbach Dennis J.  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 5, Iss. 4, 2002-10 ,pp. : 337-406

Taylor & Francis Ltd

Access to resources Recommend Favorite

Summary of the Risk Characterization Papers

By Vincent B.F.  

Regulatory Toxicology and Pharmacology, Vol. 26, Iss. 1, 1997-08 ,pp. : 69-69

Academic Press

Access to resources Recommend Favorite

Characterization of the Immune Inflammatory Profile in Obese Asthmatic Children

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 14, Iss. 3, 2014-09 ,pp. : 187-195

Bentham Science Publishers

Access to resources Recommend Favorite

Safety profile and bleeding risk of ticagrelor compared with clopidogrel

By May Christopher H   Lincoff A Michael  

Expert Opinion on Drug Safety, Vol. 11, Iss. 6, 2012-11 ,pp. : 959-967

Informa Healthcare

Access to resources Recommend Favorite